Islex Therapeutics, LLC

Baltimore, MD

UEI
ZARUWMH5JJJ5
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1812 Ashland Ave #110, Baltimore, MD 21205, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Islex Therapeutics, LLC's 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Preclinical development of a therapeutic antibody for type-1 diabetes - abstract type 1 diabetes (T1D) is a chronic… Grant · R43DK142320 National Institute of Diabetes and Digestive and Kidney Diseases $621,794
Sbir phase i: islet targeted restorative therapy for type 1 diabetes -the broader impact and commercial potential of… Grant · 2432114 National Science Foundation $275,000

Quick answers

What is Islex Therapeutics, LLC's UEI?

Islex Therapeutics, LLC's Unique Entity ID (UEI) in SAM.gov is ZARUWMH5JJJ5.

Where is Islex Therapeutics, LLC located?

Islex Therapeutics, LLC's physical address in SAM.gov is 1812 Ashland Ave #110, Baltimore, MD 21205, USA.

Is Islex Therapeutics, LLC registered in SAM.gov?

Yes. Islex Therapeutics, LLC's SAM.gov registration is active through December 2, 2026.

What is Islex Therapeutics, LLC's most recent federal award?

Islex Therapeutics, LLC's most recent federal grant award is Preclinical development of a therapeutic antibody for type-1 diabetes - abstract type 1 diabetes (T1D) is a chronic… (R43DK142320), from National Institute of Diabetes and Digestive and Kidney Diseases, on August 1, 2025.

On GovTribe

See Islex Therapeutics, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login